Bioage Labs (HAM:Y7G) Interest Received

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

HAM:Y7G Bioage Labs Inc HAM:Y7G
20 GF Score
Price €8.76
! 3 Warning Signs
View Full Analysis

What is Bioage Labs Interest Received?

Interest Received only applicable to companies reporting Cash Flow from Operations in direct method.

HAM:Y7G
20GF Score
Bioage Labs Inc HAM:Y7G
Interest Received is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Bioage Labs Business Description

Other Exchanges BIOA:USAY7G:Germany
Address 1445A South 50th Street, Richmond, CA, USA, 94804
Bioage Labs Inc is a clinical-stage biopharmaceutical company developing therapeutic product candidates for metabolic diseases by targeting the biology of human aging. The company's technology platform and differentiated human datasets enable the identification of targets based on insights into molecular changes that drive aging. The Company operates and manages its business as one reportable and operating segment, which is the business of extending healthy human life by targeting molecular causes of aging.
20GF Score

Get the complete analysis for HAM:Y7G

Interest Received is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

€8.76
Price